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INTRODUCTION 
Thrombosis of cerebral veins is a distinct cerebrovascular disorder 
that most often affects young adults and children. Cerebral venous 
thrombosis is far more common than previously assumed. The spectrum 
of its clinical presentation is extremely wide and course is highly 
variable
1
. 
There are three intracranial compartments namely the brain tissue, 
blood and CSF that if any pathology involves these will result in 
intracranial hypertension. Thrombosis of a cerebral venous sinus results 
in impediment of the sinus blood outflow. This causes increase in CSF 
pressure and increase in intracerebral venous blood pressure causing 
brain edema.  
With time, probably due to establishment of collateral venous 
circulation there is resolution of brain edema, cerebral sinus compression 
and resolution of CSF pressure. 
An occlusion of superior saggital sinus may to some degree, 
obstruct resorption of CSF by the arachnoid villi, leading to increased 
CSF pressure. But studies done so far find only small disturbance in CSF 
absorption process with only a minor contribution to intracranial pressure 
elevation
1, 2
. 
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Hence we propose to study the CSF flow dynamics by bolus saline 
infusion method and analyse its relation to the various sites of venous 
sinus thrombosis proven radiologically by MRV. 
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AIMS AND OBJECTIVES 
 
1. To study the cerebrospinal fluid opening pressure and outflow 
 resistance in patients with cerebral venous sinus thrombosis. 
2. To analyse the correlation between Intra Cerebral Pressure and the 
 site of venous sinus thrombosis. 
3. To analyse the correlation between clinical symptoms and outcome 
 with the site of sinus thrombosis. 
                  
 
 
 
 
 
 
 
 
 
 
4 
 
REVIEW OF LITERATURE 
Cerebral venous sinus thrombosis is an uncommon condition but 
over past few years has been diagnosed more often due to greater 
awareness and availability of modern neuroimaging techniques. It is a 
challenging condition due to its variability of presentation
1
. 
All age groups are affected with more common occurrence in 
females because of pregnancy, oral contraceptive use, puerperium etc. 
Septic involvement of sinus causing thrombosis was the most common 
cause previously affecting mainly cavernous sinus and transverse sinus. 
Over past few decades incidence of aseptic sinus thrombosis has 
increased with predominant involvement of superior sagittal sinus
2,3
. 
ETIOLOGY 
Predisposing factors may not be identified in upto 20% of patients 
with cerebral venous thrombosis. A general distinction can be made as 
infective and noninfective causes. Among the noninfective causes, 
connective tissue disorders, inflammatory diseases and malignancies are 
more frequent
4
. 
Prothrombotic conditions such as protein c and protein S 
deficiency, Factor V Leiden, prothrombin gene mutation and 
antithrombin III deficiency may account for 10-20% of cases of venous 
sinus thrombosis. The co-existence of other predisposing factors with 
above mentioned Prothrombotic conditions increases the risk of 
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developing sinus thrombosis. In women, it occurs more frequently during 
puerperium than pregnancy
4,5
. 
VENOUS ANATOMY 
Cerebral venous system can be divided as  
            1. Superficial system 
            2. Deep system 
1. Superficial cerebral venous system 
This comprises of  
1. Mediodorsal group draining into superior sagittal sinus and straight 
 sinus. 
2. Laterodorsal group draining into the transverse sinus. 
3. Anterior group draining into the cavernous sinus. 
The middle cerebral vein is connected to superior sagittal sinus by vein of      
Trolard and by vein of Labbe to transverse sinus
3
. 
2. Deep cerebral venous system 
The choroidal vein, septal vein and thalamostriate vein join 
together to form the internal cerebral vein. The internal cerebral veins on 
either side along with the basal veins of Rosenthal join to form the great 
vein of Galen, that drains into the straight sinus. 
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When compared to the superficial venous system,deep system is 
rather constant
3
. 
As the cerebral venous sinuses lack valves, blood flow is possible 
in all directions resulting in spread of infections. They lack tunica 
muscularis which allows them to remain dilated and have the huge 
capacity to compensate an occlusion.  
They receive blood also from meningeal, emissary and diploic 
veins resulting in frequent spread of infection from the catchment area. 
The direction of blood  draining into the superior sagittal sinus is 
against the blood flow in the sinus, causing turbulence that is further 
aggravated by the fibrous septa. This fact explains the greater prevalence 
of superior sagittal sinus thrombosis. 
The dural sinus especially the superior sagittal sinus contain most 
of the arachnoid villi and granulations, the blocking of which will lead to 
raised intracranial pressure
6
. 
PATHO-PHYSIOLOGY 
There are three intracranial compartments namely brain tissue, CSF 
and blood-that if pathologically altered can result in raised intracranial 
pressure
7
. 
 Primary thrombosis of a cerebral sinus causing impediment of the 
sinus blood outflow will increase the sagittal sinus pressure. The result is 
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increase of intracerebral venous blood pressure and volume, increase of 
CSF pressure. Finally there is impediment of cerebral function. 
 With the establishment of collateral circulation over time, there is 
resolution of brain edema and reduction of CSF pressure, resulting either 
in normalization of cerebral function or chronic stage with persistently 
elevated CSF pressure. Also, the disturbance of CSF absorption at the 
level of arachnoid villi and granulations can cause decrease of 
conductance or otherwise an increase of outflow resistance
8
. 
 Pathophysiologically, there are important differences between 
venous and arterial thrombosis. Venous sinus thrombosis is a continuous 
process in which a balance between thrombolytic and prothrombotic 
factors are disturbed leading to extension of thrombosis over time. This 
slow extension of thrombus with resulting good collateralization of 
vessels explain the gradual onset of symptoms
8,9
. 
 There must be a large area of transiently and reversibly disturbed 
cerebral tissue resulting in complete reversibility of their neurological 
deficit. The elevated venous and capillary pressure can result in 
hemorrhagic infarction in around 10- 50% of cases
10
. 
CLINICAL FEATURES  
 The onset may be acute, subacute or insidious. There are several 
different clinical constellations, 18-38% present with symptoms 
resembling benign intracranial hypertension with headache, visual 
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disturbances and papilloedema; 75% of the cases present with headache 
and focal neurological deficit;  Upto 30-50% of cases may present with 
seizures and Todd’s paralysis. There is strong overlap between all these 
groups and cases may switch over from one to the other in the course of 
their illness
6
. 
DIAGNOSIS 
 Computed tomography can be normal in 10-20% of patients with 
proven cerebral venous thrombosis. MRI combined with MRV is the 
diagnostic modality of choice. However, there are certain drawbacks of 
this technique which in some cases may make cerebral angiography 
necessary
11
. 
 One of the commonly encountered problems is the hypoplasia of the 
anterior aspect of superior sagittal sinus, a normal variant,  that can mimic 
thrombosis. Also, contrast enhancement along the edge of the thrombus 
can be mistaken for normal contrast material accumulating within a 
sinus
11,12
. 
CEREBROSPINAL FLUID DYNAMICS PHYSIOLOGY OF CSF 
PATHWAYS    
         A good knowledge of CSF dynamics is needed for understanding 
the intracranial-intraspinal changes under pathological conditions. CSF 
dynamics is a fascinating , but less explored field in neurosciences. It 
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includes all factors concerning CSF formation, circulation and absorption, 
CSF flow rate, direction and pressure etc
13
,.. 
CSF FORMATION 
 The main production site of CSF is the choroid plexus in the 
lateral,third and fourth ventricles. The formation probably takes place in 
two way, 
a. Ultrafiltration of plasma across the endothelial capillary wall, 
b. Active transport of sodium and bicarbonate by the choroidal 
 epithelium. 
 The CSF formation rate is about 0.35ml/min, 20ml/hr at a total of 
500ml/day. The movements of the cilia of the ependyma, the respiratory 
and arterial pulsations, postural changes and the pressure gradient 
between the ventricular system and the venous side of the sinuses result 
in a flow of CSF
14
. 
 
REGULATION OF ICP/CSF FORMATION 
 The balance between CSF formation and absorption in holding ICP 
constant is given by the davson equation: 
  ICP = FrRout+Pss = Er Rout + Pss 
 Where Rout is the resistance to CSF outflow,  Pss is sagittal sinus 
pressure, Er is the CSF elimination rate and Fr is the CSF formation 
rate
14,15
. 
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 ICP is normally maintained by the resistance factor of CSF 
outflow. Distension of spinal meninges, compression of venous vascular 
structures and venting of CSF constitute the major mechanisms which 
protect the brain from elevations of ICP. Regulation of CSF volume by 
means of outflow resistant factor, especially the venous part is the major 
mechanism for protection of the brain against lethal increases of ICP
16
. 
 The correlation between an increasing volume and the resulting 
pressure is known as the PV relationship and Marmarou et al introduced 
the PV index (PVI). They measured the response of CSF pressure to a 
bolus injection and calculated both compliance and resistance to CSF 
flow. 
  Rout =  tPo/PVI[ log Pt (Pp-Po)/Pp(Pt-Po) 
 Where Pp is the peak pressure, Po is opening pressure, Pt is 
instantaneous pressure at time ‘t’ on the recovery slope and t is the 
elapsed time from the instant of injection to the point at which Pt is 
determined
16,17
. 
CSF ABSORPTION 
CSF is principally absorbed through the villi valves penetrating the 
sinuses, to some extent in the villi along the spinal roots, and an unknown 
proportion is absorbed into the brain itself along the brain capillaries, 
through the ependyma and via the choroid plexus. There is a linear 
relationship between CSF absorption and ICP
14
. 
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The two main pathways of CSF absorption in the villi are either 
valve or vacuolar mechanisms. The pressure in the CSF space is higher 
than the pressure in the sagittal sinus, which is higher than in the torcular 
area of the sinuses and higher than the pressure in the jugular vein. CSF 
pressure (ICP) is related to dural sinus pressure by the formula: 
  Pss = 0.36 ICP + 36 mm H2O
15,16. 
RESISTANCE TO CSF OUTFLOW 
CSF outflow resistance  ( Rout) is the reciprocal of conductance 
and reflects the CSF absorption at the arachnoid villi. 
The aim is to measure the outflow rate of CSF from the CSF 
compartment. 
The three methods in clinical practice are 
     1. Infusion test 
a. Constant pressure servo controlled infusion method 
b. Constant infusion method 
c.  Constant infusion and constant pressure method 
All these techniques are based on identical principles of: 
a) Injecting or infusing artificial CSF intrathecally at either a constant 
 rate or constant pressure. 
b) Plotting the flow against ICP levels. 
12 
 
The slope of the regression curve is an expression of conductance 
to CSF outflow (Cout) and the reciprocal is resistance to outflow (Rout). 
The calculation of Rout implies a constant rate of CSF production and 
constant CSF and cerebral blood volumes, irrespective of the increases in 
ICP during the study
18
. 
All methods give a possibility of CSF leakage,which most often 
will result in too low Rout values. The interpretation of the pressure 
increase during the constant rate of lumbar infusion is difficult and 
unreliable,  and the constant pressure servo controlled infusion method is 
time consuming. 
The closed set up of some of the infusion methods makes 
spontaneous ICP fluctuations unavoidable, while the open system of the 
lumboventricular perfusion test makes it possible to avoid these vascular 
reactions. During the bolus injection test, definition of peak pressure, 
induced unwanted ICP changes and absence of ICP fall after obtained 
peak pressure are other sources of error
19
. 
COMPUTERISED INFUSION TEST 
By means of computerized analysis of the ICP signal a more exact 
filtration of normal fluctuations or artefacts is possible. 
Czosnyka et al. wrote  a program making it possible to measure 
Rout together with other CSF parameters in a very short time and with an 
uncomplicated set up.During lumbar infusion with a constant infusion 
13 
 
rate and monitoring of the lumbar pressure, the analogue pressure signal 
from the pressure amplifier is converted and collected in the program 
using a standard personal computer. 
The ICP signal is processed by spectral analysis, allowing filtration 
of artifacts. From the non-linear regression curve of ICP during infusion 
the program computes the static measurement of Rout, Fr and PVI. If 
steady state is not obtained, or if the infusion rate is changed during the 
test, it is possible to compute Rout from the non-linear ICP –time 
regression curve. 
Rout values measured by the computerized infusion test compared 
to values obtained by conventionally measured Rout, in patients 
representing a broad spectrum from normalcy, normal pressure 
hydrocephalus, syringomyelia to idiopathic intracranial hypertension, 
show a good correlation with no variation between Rout values from the 
two tests. 
The computerized infusion test is simple, quick, less invasive than 
a lumboventricular perfusion test and takes only 30-40 mins, including 
the lumbar puncture and the calculation. It is also faster than the steady 
state servo controlled method
17
. 
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LUMBOVENTRICULAR PERFUSION TEST: 
The lumboventricular perfusion test employs a ventricular drain 
inserted through a frontal burr hole and, after 24 hr ICP monitoring, but it 
increases the risk of complications, especially infection
18
. 
  After the 24 hr baseline ICP has been obtained, Rout is measured 
with the patient in a lateral position. The cannula in the right lateral 
ventricle is connected to the pressure monitoring system, and after the 
lumbar puncture the cannula is connected to an infusion pump.An 
infusion of ringer’s lactate starts at a rate of 0.5-2ml/min and if necessary 
this may be increased to 4-5ml/min. The outlet of the outflow tube is 
elevated in steps to increase the ICP and at each level CSF overflow is 
measured
17
. 
2.Radioisotope dilution methods 
  Radioisotope introduced intrathecally either by a 
suboccipital/lumbar route or into the ventricular system may depict 
production, transport and resorption of CSF. The tracer is followed by a 
gamma camera both in space and time over 1,6 and 24 hrs. 
 This method has been widely used to illustrate the anatomical and 
dynamic conditions of the CSF compartment, and also most recently with 
MRI, and to select patients with normal pressure hydrocephalus for CSF 
shunting
17,18
.  
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3.Bolus injection tests 
The bolus technique is fast and simple, but is based on complicated 
mathematical computations. A rapid intrathecal injection of a small 
volume –the bolus, results in an instant increase in pressure in ICP 
followed by a decline in pressure. 
The rise in ICP depends on the compliance of the craniospinal 
space and the decrease in ICP on both compliance and Rout. From the 
changes in pressure and the injected volume, Rout can be calculated.  
The bolus method seems more valuable in patients with increased ICP ( 
high elastance/low compliance), that is CVST or IIH than in patients with 
normal pressure hydrocephalus ( low elastance/high compliance)
18
. 
NORMAL Rout VALUES 
Ekstedt et al, in a study of Rout using lumbar infusion method 
found a mean Rout of 9.1 mm Hg /ml/min. Gjerris et al, confirmed that 
one measurement is sufficient and gives reliable information in patients 
with disturbances of CSF circulation
17
. 
REPRODUCIBILITY AND RELIABILITY OF ROUT 
MEASUREMENT 
The results of Rout measurement over more than one examination 
in 146 patients with normal pressure hydrocephalus and idiopathic 
16 
 
intracranial hypertension in both ventricular and lumbar infusion test are 
reproducible and reliable. 
Borgesan described a variation of not more than 5% during 
repeated Cout measurement, and the same was found with only a short 
interval between two Rout measurements. 
The Copenhagen group found a high correlation between Rout 
values obtained from the ventricular and lumbar route. They also 
demonstrated that atleast 6hrs to elapse after insertion of the ventricular 
catheter before measurement of Rout is performed and that one 
measurement is sufficient and gives reliable information in patients with 
disturbances of CSF circulation
18,19
.  
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MATERIALS AND METHODS 
The study was done at Institute of Neurology, Government General 
Hospital and Madras Medical College, Chennai during the period of 
September 2010 to January 2013. 
Patients admitted in the hospital with the clinical suspicion of 
cerebral venous sinus thrombosis were included in the study after 
confirming the diagnosis by MRI with MRV. 
Detailed clinical history and examination were recorded.  Among 
this group those patients with general contraindications for lumbar 
puncture procedure such as bleeding disorders, thrombocytopenia(platelet 
count <100,000), unequal supratentorial pressure, skin infection at 
puncture site etc.. were excluded. 
All those included in the study were subjected to lumbar puncture 
and CSF flow dynamics study by modified bolus injection method,  the 
MIN method using bedside saline manometer. 
METHOD OF CSF DYNAMICS STUDY: 
Bolus injection method modified at the Madras Institute Of 
Neurology using a simplified bedside saline manometer and standardized 
by VG Ramesh et al has been used for studying the CSF flow dynamics
20
. 
Patient is positioned in left lateral position for performing lumbar 
puncture. The equipment consists of 20G lumbar puncture needle, a 
18 
 
saline stand,measuring tape,3-way adapter, intravenous set and normal 
saline. The measuring tape is mounted on the saline stand. The 
intravenous set is filled with normal saline upto 11cms, which in turn is 
mounted over the saline stand. The zero level should correspond to the 
spine of the patient in left lateral position. 
Now lumbar puncture is performed in the L3-L4 interspace and the 
needle is connected to the 3-way adapter. The opening pressure is (Po) is 
noted down after the saline column stabilizes.  A volume of normal saline 
(rV),which is usually 5-10 ml is injected into the intrathecal space at the 
rate of 1ml/sec, through the three way adapter. After the saline column 
stabilizes the peak pressure (Pp) is noted down. After the elapse of 
particular time, which is t in minutes, Pt is recorded. Rout (CSF outflow 
resistance) is calculated using  the Marmarou’s Formula, which is as 
follows, 
PVI  =   rV/log (Pp/Po) 
Rout  =  tPo/PVI[log Pt(Pp-Po)/Pp(Pt-Po)] cms of water/ml/min. 
The final value is divided by 1.36 to convert it into 
mmHg/ml/min
20
.  
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RESULTS AND ANALYSIS 
AGEWISE DISTRIBUTION OF CASES 
Among the total 30 cases, the minimum age is 14yrs and the 
maximum age is 47 yrs. Mean age is 31yrs. Hence, our study group is 
distributed over young adult population as shown in Table 1.  
 
Statistics Age 
N 30 
Mean 31.00 
Minimum 14 
Maximum 47 
Table 1. 
GENDER DISTRIBUTION 
 Among the total of 30 cases, 16 were male and 14 were female as 
shown  in Table 2&fig 1. 
 
 
Gender Frequency Percent 
Male 16 53.3 
Female 14 46.7 
Total 30 100.0 
Table  2. 
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Fig 1.Gender Distribution 
FREQUENCY DISTRIBUTION OF SYMPTOMS 
Only 13.3% of study patients did not complain of headache, 
whereas the majority i.e. 86.7% did have headache as the presenting 
complaint as shown in Table 3. 
 
    Table 3. 
Gender Distribution
Male
Female
Headache Frequency Percent 
Nil 4 13.3 
Present 26 86.7 
Total 30 100.0 
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As shown in table 4., 18 cases had papilledema attributing to a 
majority of 60%. 12 cases did not have papilledema at admission. 
 
Papilledema Frequency Percent 
Nil 12 40.0 
Present 18 60.0 
Total 30 100.0 
Table 4. 
FREQUENCY DISTRIBUTION OF SINUS THROMBOSIS 
17 cases had thrombosis involving superior sagittal sinus, which 
accounts for a total of 56.7%. Transverse sinus is also equally involved 
with 56.7%, Sigmoid sinus in 30% of cases and Straight Sinus in 10% of 
cases were involved. These are shown in Table 5,6,7,8 respectively & fig 
2.. 
SSS Frequency Percent 
No 13 43.3 
Yes 17 56.7 
Total 30 100.0 
Table 5. 
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Transverse Sinus Frequency Percent 
No 13 43.3 
Yes 17 56.7 
Total 30 100.0 
Table 6. 
 
Sigmoid Sinus Frequency Percent 
No 21 70.0 
Yes 9 30.0 
Total 30 100.0 
Table 7. 
 
Straight Sinus Frequency Percent 
No 27 90.0 
Yes 3 10.0 
Total 30 100.0 
Table 8. 
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Fig 2. Frequency distribution of sites of sinus thrombosis 
 
CSF PROTEIN 
11 cases (36.7%) , had CSF protein level outside the normal range 
of 40 mg/dl,(Table 9).  
 
 
 
 
 
Table 9. 
Sinus Thrombosis
Straight Sinus
Sigmoid Sinus
Transverse Sinus
SSS
CSF protein Frequency Percent 
< 40 mg/dl 19 63.3 
> 40 mg/dl 11 36.7 
Total 30 100.0 
24 
 
CSF CELL COUNT 
Only one among the 30 cases had an abnormal CSF cell count  >5 cells/ 
dl.  The CSF cell count was normal in 96.7% of cases as shown in Table 
10. 
CSF cell count Frequency Percent 
≤ 5 29 96.7 
> 5 1 3.3 
Total 30 100.0 
Table 10. 
 
CLINICAL OUTCOME ANALYSIS 
14 patients had shown improvement in clinical symptoms, whereas 
the majority i.e. 16 patients (53.3%) complained of persistent 
headache.(Table 11)&fig 3. 
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Outcome Frequency Percent 
Improved 14 46.7 
Persistent Headache 16 53.3 
Total 30 100.0 
 
Table11. 
 
Fig 3. Analysis of sinus thrombosis with head ache, 
papilledema &clinical outcome . 
 
FREQUENCY DISTRBUTION OF Po AND Rout 
As shown in Table 12 and Table 13, the mean opening pressure 
was 21.90 cm H2O and the mean Rout was 41.83 mm Hg /ml /min. The 
maximum and minimum Rout measured were 73 mm Hg/ml/min and 6 
mm Hg/ml/min respectively. 
0.00%
50.00%
100.00%
150.00%
200.00%
250.00%
Persistent 
Headache
Papilledema
Headache
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Statistics Po (cm H2o) 
N 30 
Mean 21.90 
Minimum 10 
Maximum 72 
 
Table 12. 
 
Statistics Rout (mm Hg) 
N 30 
Mean 41.83 
Minimum 6 
Maximum 73 
 
Table 13. 
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ANALYSIS OF Rout AND Po IN RELATION TO SINUS 
THROMBOSIS 
The independent samples t-test has shown statistical significance 
for elevated Rout in relation to the site of sinus thrombosis in patients 
with Superior sagittal sinus  ( P value = 0.001) and straight sinus (P value 
= 0.001).This is shown in Table 14,Table 17&fig 4. 
However, the level of  opening pressure (Po) rise has not shown 
any statistically significant relation with the site of sinus thrombosis. 
 Independent samples t-test to compare the mean values  
 
 
SSS N Mean 
Std. 
Deviation P-Value 
Rout (mm Hg) No 13 26.27 13.933 0.001 
Yes 17 53.74 18.582 
Po (cm H2o) No 13 21.46 16.277 0.857 
Yes 17 22.24 6.026 
 
Table 14. 
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 Transverse 
Sinus N Mean 
Std. 
Deviation P-Value 
Rout (mm Hg) No 13 46.12 18.087  
0.349 Yes 17 38.56 23.803 
Po (cm H2o) No 13 19.46 5.753  
0.314 Yes 17 23.76 14.211 
 
Table 15. 
 
 Sigmoid 
Sinus N Mean 
Std. 
Deviation P-Value 
Rout (mm Hg) No 21 39.83 21.013 0.446 
Yes 9 46.50 23.188 
Po (cm H2o) No 21 23.52 12.632 0.240 
Yes 9 18.11 6.972 
 
Table 16. 
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 Straight 
Sinus N Mean 
Std. 
Deviation P-Value 
Rout (mm Hg) No 27 39.31 21.199 0.001 
Yes 3 64.55 1.928 
Po (cm H2o) No 27 21.30 11.711 0.393 
Yes 3 27.33 7.095 
 
Table 17. 
 
 
Fig 4.Analysis of sinus thrombosis with Rout, 
Papilledema & Headache. 
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ANALYSIS OF Rout AND PO IN RELATION TO CLINICAL 
SYMPTOMS 
       The mean Rout in patients with and without headache were 42.65 
and 36.55 respectively. The outflow resistance is in a higher range in 
those presenting with headache, but this has not shown statistical 
significance ( P = 0.606). Table 18. 
The mean opening pressure in patients with headache was 22.50, 
which is in a higher range when compared to those without headache ( 
mean =18.00). However, this is not found to be significant statistically 
(P=0.472).Table 18 
                
 
Headache N Mean 
Std. 
Deviation P Value 
         Rout (mm 
Hg) 
Nil 4 36.55 21.999 0.606 
Present 26 42.65 21.755 
     Po (cm 
H2o) 
Nil 4 18.00 4.967 0.472 
Present 26 22.50 12.034 
 
Table 18. 
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The mean Rout (49.35) is also at a higher range in patients with 
papilledema when compared to those without papilledema (mean Rout = 
30.56). This has shown significance statistically also (P = 0.016).Table 
19. 
The mean Po (25.00) is at a higher range in patients with 
papilledema than in patients without papilledema (mean Po =17.25). This 
is significant statistically with a P value of 0.067. Table 19.  
 
 
Papilledema N Mean 
Std. 
Deviation P-Value 
Rout (mm 
Hg) 
Nil 12 30.56 20.247 0.016 
Present 18 49.35 19.345 
Po (cm 
H2o) 
Nil 12 17.25 6.904 0.067 
Present 18 25.00 12.852 
 
Table 19. 
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ANALYSIS OF Rout AND Po IN RELATION TO CLINICAL 
OUTCOME 
In patients who complained of persistent headache , the mean Rout 
is high (49.81 ) and this is statistically significant ( P =0.027 ). 
The mean  Po in patients with persistent headache was 20.56 and in 
those who improved was 23.43.Table 20.   
 
 
Outcome N Mean 
Std. 
Deviation P-Value 
Rout (mm 
Hg) 
Improved 14 32.72 21.339 0.027 
Persistent 
Headache 
16 49.81 18.822 
Po (cm 
H2o) 
Improved 14 23.43 16.190 0.531 
Persistent 
Headache 
16 20.56 4.442 
                                      
Table 20. 
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ANALYSIS OF CLINICAL SYMPTOMS WITH SINUS 
THROMBOSIS 
Among the 17 patients who had SSS thrombosis, 14 complained of 
headache ( P = 0.613 ). 16 among 17 patients who had transverse sinus 
thrombosis complained of headache ( P = 0.290), 8 out of 9 patients with 
sigmoid sinus thrombosis had headache ( P = 0.999), all the 3 patients 
with straight sinus involvement had headache ( P = 0.999). Tables 
21,22,23,24.  
Cross Tables 
Chi-Square test to compare the proportions 
SSS Headache Total 
 Nil Present 
N % N % N % 
No 1 25.0 12 46.2 13 43.3 
Yes 3 75.0 14 53.8 17 56.7 
Total 4 100.0 26 100.0 30 100.0 
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Chi-Square Tests P-Value 
Fisher's Exact Test 0.613 
 
Table 21. 
 
Transverse 
Sinus 
Headache Total 
 Nil Present 
N % N % N % 
No 3 75.0 10 38.5 13 43.3 
Yes 1 25.0 16 61.5 17 56.7 
Total 4 100.0 26 100.0 30 100.0 
 
Chi-Square Tests P-Value 
Fisher's Exact Test 0.290 
 
Table 22. 
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Sigmoid 
Sinus 
Headache Total 
 Nil Present 
N % N % N % 
No 3 75.0 18 69.2 21 70.0 
Yes 1 25.0 8 30.8 9 30.0 
Total 4 100.0 26 100.0 30 100.0 
 
 
Chi-Square Tests P-Value 
Fisher's Exact Test 0.999 
 
Table 23. 
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STRAIGHT 
SINUS 
Headache Total 
 Nil Present 
N % N % N % 
No 4 100.0 23 88.5 27 90.0 
Yes 0 .0 3 11.5 3 10.0 
Total 4 100.0 26 100.0 30 100.0 
 
Chi-Square Tests P-Value 
Fisher's Exact Test 0.999 
 
Table 24. 
72.2% of those with SSS thrombosis had papilledema with 
significant P value of 0.035.Table 25. 
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SSS Papilledema Total 
 Nil Present 
N % N % N % 
No 8 66.7 5 27.8 13 43.3 
Yes 4 33.3 13 72.2 17 56.7 
Total 12 100.0 18 100.0 30 100.0 
 
Chi-Square Tests P-Value 
Pearson Chi-Square 0.035 
 
Table 25 
 
44.4% with transverse sinus involvement had papilledema with 
P=0.098.Table 26. 
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Transverse 
Sinus 
Papilledema Total 
 Nil Present 
N % N % N % 
No 3 25.0 10 55.6 13 43.3 
Yes 9 75.0 8 44.4 17 56.7 
Total 12 100.0 18 100.0 30 100.0 
 
 
Chi-Square Tests P-Value 
Pearson Chi-Square 0.098 
 
Table 26. 
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33.3% of those with sigmoid sinus thrombosis (P =0.704), 11.1% 
with straight sinus involvement had papilledema ( P =0.999). Table 27, 
28. 
 
SIGMOID 
SINUS 
Papilledema Total 
 Nil Present 
N % N % N % 
No 9 75.0 12 66.7 21 70.0 
Yes 3 25.0 6 33.3 9 30.0 
Total 12 100.0 18 100.0 30 100.0 
 
 
Chi-Square Tests P-Value 
Fisher's Exact Test 0.704 
 
Table 27. 
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STRAIGHT 
SINUS 
Papilledema Total 
 Nil Present 
N % N % N % 
No 11 91.7 16 88.9 27 90.0 
Yes 1 8.3 2 11.1 3 10.0 
Total 12 100.0 18 100.0 30 100.0 
 
 
Chi-Square Tests P-Value 
Fisher's Exact Test 0.999 
 
Table 28. 
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ANALYSIS OF RELATION OF SINUS THROMBOSIS WITH 
CLINICAL OUTCOME 
75% of patients with SSS thrombosis complained of persistent 
headache which has shown statistical significance also ( P =0.030 ).Table 
29. 
 
SSS Outcome 
Total 
 Improved 
Persistent 
Headache 
N % N % N % 
No 9 64.3 4 25.0 13 43.3 
Yes 5 35.7 12 75.0 17 56.7 
Total 14 100.0 16 100.0 30 100.0 
 
Chi-Square Tests P-Value 
Pearson Chi-Square 0.030 
 
Table 29. 
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 37.5% of patients with transverse sinus thrombosis had persistent 
headache with a significant P value of 0.024.Table 30. 
 
TRANSVERSE 
SINUS 
Outcome 
Total 
 Improved 
Persistent 
Headache 
N % N % N % 
No 3 21.4 10 62.5 13 43.3 
Yes 11 78.6 6 37.5 17 56.7 
Total 14 100.0 16 100.0 30 100.0 
 
Chi-Square Tests P-Value 
Pearson Chi-Square 0.024 
 
Table 30. 
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25% of patients with sigmoid sinus thrombosis had persistent 
headache ( P =0.694 ).Table 31. 
12.5% of patients with straight sinus thrombosis had persistent 
symptoms ( P =0.999). Table 32. 
 
SIGMOID 
SINUS 
Outcome 
Total 
 Improved 
Persistent 
Headache 
N % N % N % 
No 9 64.3 12 75.0 21 70.0 
Yes 5 35.7 4 25.0 9 30.0 
Total 14 100.0 16 100.0 30 100.0 
 
Chi-Square Tests P-Value 
Fisher's Exact Test 0.694 
 
Table 31. 
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STRAIGHT 
SINUS 
Outcome 
Total 
 Improved 
Persistent 
Headache 
N % N % N % 
No 13 92.9 14 87.5 27 90.0 
Yes 1 7.1 2 12.5 3 10.0 
Total 14 100.0 16 100.0 30 100.0 
 
 
Chi-Square Tests P-Value 
Fisher's Exact Test 0.999 
 
Table 32. 
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DISCUSSION 
 
Cerebral venous thrombosis  commonly affects young adult 
population mainly females during pregnancy and puerperium. This 
condition is being diagnosed more frequently now a days, owing to high 
clinical suspicion and advent of modern neuroimaging modalities like 
MRI, MRV and CT Venography. 
Early diagnosis and highly active interventional treatment 
approaches have led to considerable reduction in morbidity and mortality 
over the past few decades
22,23
. 
In developing countries like India,  a significant change in the 
causative factor has been observed for past few years. Unlike septic 
causes, aseptic conditions such as antiphospholipid antibody syndrome, 
inflammatory diseases, prothrombotic conditions like prothrombin gene 
mutation, Factor V Leiden, Antithrombin III 
deficiency,hyperhomocystinemia etc, have become common etiological 
factors
24,25
.  
 The presence of other secondary risk factors like oral contraceptive 
use, alcohol consumption and dehydration in persons already affected 
with prothrombotic mutations lead to increased incidence of CVST. With 
the availability of improved laboratory facilities, now  we are able to find 
out etiology in more number of patients
26
.     
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 The venous sinuses are the main drainage channels for the 
cerebrospinal fluid,especially the superior sagittal sinus due to plenty of 
arachnoid villi and granulations. In CVST, there is significant disturbance 
of CSF flow and absorption because of increasing pressure in the 
thrombosed sinus. This is a condition with high elastance and low 
compliance
27
. 
 According to the Munro-Kellie doctrine, this in turn will lead to 
raised intracranial pressure.This basic pathophysiology is the reason 
behind the patients clinically presenting with severe headache and 
papilledema
28,30
. 
 Early diagnosis and treatment helps in lowering the ICP by 
recanalising the venous sinus. Over time, there will be establishment of 
collaterals which may also lead to better drainage of CSF
31
.  
 In practical clinical situations, we were able to observe that more 
often patients who have suffered venous sinus thrombosis visit the 
outpatient clinic complaining of persistent headache. The persistence of 
headache is a huge burden for the patient affecting their productive life.  
Pathophysiologically, this may be attributed to the permanently 
altered CSF flow dynamics, the study of which may help us for better 
understanding of this common clinical problem. Hence we attempted to 
study the CSF flow dynamics in patients affected with CVST. 
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We measured the CSF opening pressure by performing lumbar 
puncture. We used the MIN modified Bolus injection method to measure 
the Rout ( outflow resistance), which is the reciprocal of compliance. Our 
method is simplified modification of the well accepted Marmarou’s  
Bolus injection test, which can be performed bedside using a saline 
manometer. This method has been studied and standardized by VG 
Ramesh et al
20
. 
Previously in our institute the same method was used in the study 
by Vidhya et al in patients with NPH (19 patients), Post traumatic 
hydrocephalus (23 patients) and Post meningitic hydrocephalus (8 
patients). They have measured the Rout and shown good prognosis after 
shunt surgery done based the threshold Rout values. 
Mahesh et al from our institute have studied the CSF flow 
dynamics in patients with IIH (47 cases ) and have shown that 
measurement of Rout along with CSF opening pressure will increase the 
diagnostic possibility of IIH from 60% to 90%. 
Our study is a cross sectional study including 30 patients diagnosed 
as CVST confirmed with MRI/MRV, for whom we have measured the 
CSF flow dynamics. 
The mean age of the study group is 31 yrs. Among the total 30 
cases, 16 were male and 14 were female. 86.7% did complain of 
headache and 60% had papilledema. 56.7% of the study group had SSS 
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thrombosis, transverse sinus thrombosis in 56.7%, 30% had sigmoid sinus 
thrombosis and 10% had straight sinus thrombosis. Of the total 53.3% 
had persistent headache even after treatment. Among those who 
complained of persistent headache, 75% had SSS thrombosis ( P=0.035).  
The mean Rout is 41.83 mm Hg/ml/min and higher range of Rout 
was present in patients with SSS thrombosis (P=0.001).  
The mean Rout in those with persistent headache was in a higher  
range (49.81mm Hg/ml/min) with P=0.027. 72.2% with SSS thrombosis 
had papilledema ( P=0.035). 
Hence, in our study SSS and transverse sinus were commonly 
affected. The raised ICP symptoms such as headache and papilledema 
were more common in those with SSS thrombosis. The mean Rout and 
Po in patients with superior sagittal sinus thrombosis were at a higher 
range, when compared to other sites of sinus thrombosis. This explains 
the reduced compliance of CSF drainage in patients with SSS thrombosis 
leading to altered CSF flow dynamics and in turn raised ICP. 
Also,the same group of patients with involvement of SSS 
thrombosis with high Po and Rout did complain of persistent headache 
even after medical treatment. 
Only few studies have been done so far regarding CSF flow 
dynamics in CVST, among them the notable one is study by Ekstedt et 
al
21
 in 10 patients with SSS thrombosis. They have studied the CSF 
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dynamics by constant pressure infusion method and followed up over a 
period of 15 yrs. A total of 70 dynamic studies were done.  
They have concluded that there was a clear increase in intracranial 
pressure due to rise in pressure of major dural sinus. There was a 
persistent increase in ICP which declined only gradually. But according 
to them this had no significant clinical impact as change in CSF 
absorption played only a minor role in elevating the ICP and none of the 
patients developed hydrocephalus.  
However, in our study we were able to demonstrate that reduced 
compliance or elevated outflow resistance significantly contributes to the 
raised ICP especially in those with involvement of SSS thrombosis. Also, 
we were able to show that this had significant clinical impact over the 
patient in the form of persistent headache.  
Park et al
29, in their study of ‘New Concept of cerebrospinal fluid 
dynamics in cerebral venous sinus thrombosis’ have stated that , sagittal 
sinus differs from other sinuses in that greater impediment of CSF 
absorption occurs due to presence of arachnoid villi in these sinuses 
which will contribute to greater rise in ICP, leading to a higher likelihood 
of ventricular dilatation.  
However , they have observed that external CSF drainage did not 
improve sinus thrombosis in these patients and one should be careful 
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while performing external CSF drainage in patients with sagittal sinus 
involvement. 
In our study we were able to demonstrate that increased outflow 
resistance especially in major dural sinus thrombosis is the major 
contributing factor towards raised intracranial pressure and that higher 
Rout at diagnosis mostly leads to persistent headache in this group of 
patients producing significant clinical impact.                         
However, these patients need to be followed up for a longer 
duration with repeat CSF dynamic studies and neuroimaging, so that the 
requirement of additional long term treatment  to reduce raised ICP can 
be recommended.  
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CONCLUSION 
 
1. The cerebrospinal fluid opening pressure Po and the outflow 
 resistance Rout were in a higher range in patients with cerebral 
 venous sinus thrombosis. 
2. The opening pressure Po and outflow resistance Rout were higher 
 in patients with superior sagittal sinus thrombosis when compared 
 to other sites of sinus involvement. 
3. The patients with superior sagittal sinus thrombosis had the higher 
 incidence of headache ,papilledema and also did complain of 
 persistent headache even after medical treatment. 
4. The increase in Rout suggests that the raised ICP due to reduced 
 compliance will take longer time to normalise inspite of 
 recanalisation secondary to anticoagulant therapy. 
5. In view of persistent headache, these patients will require long term 
 medical treatment for raised ICP. 
6. For unexplained reasons, these group of patients do not develop 
 hydrocephalus inspite of raised ICP. 
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ABBREVIATIONS 
CSF        :   Cerebrospinal Fluid 
ICP         :   Intracranial Pressure 
CVST     :   Cerebral Venous Sinus Thrombosis 
MRI        :   Magnetic Resonance Imaging 
MRV       :  Magnetic Resonance Venography 
Po        :   Opening Pressure 
Pp          :   Peak Pressure 
PVI         :   Pressure Volume Index 
Rout       :   Outflow Resistance 
Cout       :   Conductance to Outflow 
IIH          :   Idiopathic Intracranial Hypertension 
NPH        :   Normal Pressure Hydrocephalus 
CT          :  Computed Tomography 
MIN        :  Madras Institute Of Neurology 
  
PROFORMA 
Name :     Serial No : 
Age :      IP No : 
Sex :      Address : 
DOA : 
DOD:      Phone No : 
Diagnosis :     DO Dynamics study : 
History : 
 
Clinical Finding : 
 
Investigations : 
1. Radiology –   
1. CT Brain 
2. MRI Brain with MRA and MRV 
3. CSF Analysis 
 
CSF Flow Dynamics : 
P0 :   PP :  Pt :  t :  rv : 
PVI : 
Rout : 
Clinical Outcome : 
 
2 32 M present present 1week no deficit 23 24.14 54.21
SSS,LT 
transverse,sigmoid sinus 34mg/dl 53mg/dl no cells improved
3 40 F present present 10 days no deficit 12 22.62 49.29
Lt sigmoid sinus 
thrombosis 72mg/dl 48mg/dl no cells
persistent 
headache
4 14 F present nil 2weeks rt ear discharge 10 13.81 34.85
rt sigmoid sinus 
thrombosis 75mg/dl 44mg/dl no cells improved
5 33 M present present 1month
b/L lateral rectus 
palsy,diplopia 21 27.53 73.45
sss,RT 
transverse,sigmoid sinus 40mg/dl 70mg/dl no cells
persistent 
headache
6 27 M present present 1month diplopia 18 34.32 62.45
SSS /rt frontotemporal 
h'rhage 25mg/dl 74mg/dl no cells
persistent 
headache
7 30 M present nil 3 days no deficit 10 24.51 5.86
rt transverse/sigmoid 
sinus 35mg/dl 55mg/dl 2 lym improved
8 45 F present present 20days diplopia 31 32.89 43.86
rt transverse/sigmoid 
sinus 75mg/dl 46mg/dl 5 lym improved
9 30 M present present 5days
Lt hemiparesis/UMN 
facial palsy 26 22.83 65.89 SSS/straight sinus 40 mg/dl 73mg/dl no cells
persistent 
headache
10 32 F present present 10days rt hemiparesis/GTCS 33 24.56 70.89 SSS/rt transverse sinus 24mg/dl 105mg/dl 3lym improved
11 46 M present present 4days
Lt hemiparesis/UMN 
facial palsy 20 32.32 65.34
SSS/rt 
transverse/sigmoid sinus 20mg/dl 62mg/dl no cells
persistent 
headache
12 32 M nil present 10days rt hemiparesis/GTCS 16 21.76 58.97
SSS/bl frontal h'hagic 
infarct 40mg/dl 72mg/dl 2lym improved
13 35 M present nil 1month
rt hemiparesis/rt focal 
seizures 35 31.35 62.34
SSS/rt 
transverse/straight sinus 45mg/dl 79mg/dl no cells improved
14 28 M present nil 1month Lt focal seizure 15 24.67 71.89
SSS/rt 
transverse/sigmoid sinus 43mg/dl 76mg/dl no cells
persistent 
headache
15 47 M present present 3months no deficit 15 23.14 21.67
Rt transverse sinus 
thrombosis 34mg/dl 89mg/dl 4lym improved
Papilledema
Po(cm 
H2o)
Rt transverse sinus 
thrombosis
Duration
221 F present 1month
Serial 
no. Age Sex
present
Headache
vision lose 
(neurobrucellosis) 72 23.13 11.7 210mg/dl
CSF 
CellsPVI
Rout (mm 
Hg)
MRI Brain With 
MRVClinical features Outcome
98mgs/dl 10 lym improved
CSF Protein CSF Sugar
16 24 F present nil 15days no deficit 15 25.65 18.9
Rt transverse sinus 
thrombosis 32mg/dl 98mg/dl no cells improved
17 34 M present present 10days diplopia 21 32.76 65.42 SSS/straight sinus 45mg/dl 108mg/dl no cells
persistent 
headache
18 45 F nil present 5days GTCS 23 25.76 51.78 SSS thrmbosis 40mg/dl 100mg/dl 2lym
persistent 
headache
19 21 F present nil 1month rt focal seizure 25 31.45 32.65
Lt transverse sinus 
thrombosis 32mg/dl 105mg/dl no cells
persistent 
headache
20 25 M present present 15days no deficit 26 21.32 59.8 SSS thrmbosis 45mg/dl 97mg/dl no cells
persistent 
headache
21 32 F present nil 1month rt hemiparesis 18 23.12 23.78
Lt transverse sinus 
thrombosis 32mg/dl 100mg/dl 2lym improved
22 43 M nil present 12days GTCS 21 23.56 19.78
LT transverse/sigmoid 
sinus 42mg/dl 99mg/dl 3lym improved
23 23 F present nil 3months no deficit 18 21.45 46.76
Rt transverse sinus 
thrombosis 46mg/dl 87mg/dl no cells
persistent 
headache
24 31 F present nil 1month no deficit 17 20.98 21.65 SSS thrmbosis 43mg/dl 76mg/dl no cells
persistent 
headache
25 22 F present present 3days no deficit 25 23.56 43.21 SSS thrmbosis 40mg/dl 65mg/dl no cells
persistent 
headache
26 34 M present nil 15days rt focal seizure 17 21.21 15.65
Rt transverse sinus 
thrombosis 42mg/dl 89mg/dl no cells improved
27 21 M present present 20days no deficit 21 24.32 17.89 SSS thrmbosis 40mg/dl 90mg/dl 2lym
persistent 
headache
28 43 M present nil 1month no deficit 15 21.2 16.75
Lt  transverse/sigmoid 
sinus 32mg/dl 102mg/dl no cells
persistent 
headache
29 20 F nil nil 2days GTCS 12 25.56 15.67 SSS thrmbosis 25mg/dl 100mg/dl no cells improved
30 19 F present present 1month no deficit 26 21.23 52.67 SSS thrmbosis 34mg/dl 98mg/dl 3lym
persistent 
headache
  
